COVID-19 antivirals must not affect HIV drug supply.

Barber, Melissa; Sarpatwari, Ameet; Cepuch, Christa

Barber, Melissa; Sarpatwari, Ameet; Cepuch, Christa.

Barber M; Department of Global Health and Population, Harvard T H Chan School of Public Health, Boston, MA 02115, USA. Electronic address: melissabarber@g.harvard.edu.
Sarpatwari A; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Cepuch C; Access Campaign, Médecins sans Frontières, Geneva, Switzerland.

Lancet HIV ; 9(1): e7-e9, 2022 01.

Article in English | MEDLINE | ID: covidwho-1562191

Subject(s)

Antiviral Agents; COVID-19 Drug Treatment; HIV Infections; Antiviral Agents/supply & distribution; Antiviral Agents/therapeutic use; HIV Infections/drug therapy; Humans

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / HIV Infections / COVID-19 Drug Treatment Limits: Humans Language: English Journal: Lancet HIV Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google